Invesaro

Stocks Comparison

RxSight vs Warby Parker: revenue, profit, margins and growth compared

RxSight brought in $134.5M of revenue in fiscal 2025, Warby Parker $871.9M in fiscal 2025. Revenue changed by -3.9% at RxSight and +13.0% at Warby Parker on the year before, so Warby Parker grew faster. RxSight kept -29.0% of its revenue as net profit, Warby Parker 0.2%. Free cash flow was -$19.3M at RxSight and $43.7M at Warby Parker.

Side by side, latest fiscal year

RXSTWRBY
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$134.5M$871.9M
Revenue growth-3.9%+13.0%
Net income-$38.9M$1.6M
Net margin-29.0%0.2%
Free cash flow-$19.3M$43.7M
Free cash flow margin-14.4%5.0%
Earnings per share (diluted)-$0.95$0.01
Cash$19.9M$286.4M
Debtn/an/a
Price to earningsn/a2671.0
Market value$193.8M$3.3B
Dividend yieldn/an/a
Rank by revenue in sector#279 of 523 · Health care#155 of 523 · Health care

Over the years

Revenue
RXST FY2021: $14.7MRXST FY2021: $22.6MRXST FY2022: $49MRXST FY2023: $89.1MRXST FY2024: $139.9MRXST FY2025: $134.5MWRBY FY2019: $370.5MWRBY FY2021: $393.7MWRBY FY2021: $540.8MWRBY FY2022: $598.1MWRBY FY2023: $669.8MWRBY FY2024: $771.3MWRBY FY2025: $871.9MFY19FY21FY22FY23FY24FY25
RXST $134.5MWRBY $871.9M
Net income
RXST FY2021: $27.6MRXST FY2021: -$48.7MRXST FY2022: -$66.8MRXST FY2023: -$48.6MRXST FY2024: -$27.5MRXST FY2025: -$38.9MWRBY FY2019: $0WRBY FY2021: -$55.9MWRBY FY2021: -$144.3MWRBY FY2022: -$110.4MWRBY FY2023: -$63.2MWRBY FY2024: -$20.4MWRBY FY2025: $1.6MFY19FY21FY22FY23FY24FY25
RXST -$38.9MWRBY $1.6M
Net margin
RXST FY2021: 187.9%RXST FY2021: -215.5%RXST FY2022: -136.2%RXST FY2023: -54.6%RXST FY2024: -19.6%RXST FY2025: -29.0%WRBY FY2019: 0.0%WRBY FY2021: -14.2%WRBY FY2021: -26.7%WRBY FY2022: -18.5%WRBY FY2023: -9.4%WRBY FY2024: -2.6%WRBY FY2025: 0.2%FY19FY21FY22FY23FY24FY25
RXST -29.0%WRBY 0.2%
Revenue growth
RXST FY2021: +53.9%RXST FY2022: +116.9%RXST FY2023: +81.8%RXST FY2024: +57.1%RXST FY2025: -3.9%WRBY FY2021: +6.3%WRBY FY2021: +37.4%WRBY FY2022: +10.6%WRBY FY2023: +12.0%WRBY FY2024: +15.2%WRBY FY2025: +13.0%FY21FY22FY23FY24FY25
RXST -3.9%WRBY +13.0%
Free cash flow
RXST FY2021: -$37.7MRXST FY2021: -$46.6MRXST FY2022: -$61.2MRXST FY2023: -$46.4MRXST FY2024: -$22.4MRXST FY2025: -$19.3MWRBY FY2019: -$11.2MWRBY FY2021: $12.7MWRBY FY2021: -$80.5MWRBY FY2022: -$49.8MWRBY FY2023: $7.3MWRBY FY2024: $34.7MWRBY FY2025: $43.7MFY19FY21FY22FY23FY24FY25
RXST -$19.3MWRBY $43.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about RxSight and Warby Parker

Which is bigger by revenue, RxSight or Warby Parker?

Warby Parker is bigger by revenue: $871.9M in fiscal 2025, against $134.5M for RxSight in fiscal 2025.

Which keeps more of its revenue as profit, RxSight or Warby Parker?

RxSight had a net margin of -29.0% in fiscal 2025; Warby Parker had 0.2% in fiscal 2025.

Which grew revenue faster, RxSight or Warby Parker?

In their latest fiscal years revenue changed by -3.9% at RxSight and +13.0% at Warby Parker.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies